RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Helius Medical Technologies Stock

Helius Medical Technologies P/S 2024

Helius Medical Technologies P/S

1.78

Ticker

HSDT

ISIN

US42328V6039

WKN

A2JB8E

As of Dec 20, 2024, Helius Medical Technologies's P/S ratio stood at 1.78, a -75.04% change from the 7.13 P/S ratio recorded in the previous year.

The Helius Medical Technologies P/S history

Helius Medical Technologies Aktienanalyse

What does Helius Medical Technologies do?

Helius Medical Technologies Inc is a Canadian company that specializes in the development and marketing of novel medical devices. The company was founded in 2014 and has since experienced remarkable success. The company's main product is the Portable Neuromodulation Stimulation (PoNS) treatment, which offers a non-invasive therapy for conditions such as stroke, traumatic brain injury, or multiple sclerosis. It is a portable device applied to the patient's tongue, emitting weak electrical impulses to promote neural stimulation. The accompanying software allows clinics and hospitals to offer personalized treatment to patients. Helius Medical Technologies Inc is divided into various divisions to better organize its operations: development, sales, and research and development. The different divisions are designed to operate the core business independently. The company operates in North America, with its headquarters in Newtown, Pennsylvania. However, it also operates in Canada and other regions, including Europe, Latin America, and Asia. Helius Medical Technologies Inc maintains close ties to the scientific community to ensure its products are up to date. The company has also partnered with the Walter Reed National Military Medical Center to explore the potential of its PoNS technology in treating post-traumatic stress disorder (PTSD) in US military personnel and veterans. The business model of Helius Medical Technologies Inc is based on innovative solutions that enable top-notch medical treatments. Through continuous research and development, the company remains at the forefront of the medical technology industry. Helius Medical Technologies Inc is focused on growth, reflected in its ongoing search for new markets and products. In recent years, the company has experienced significant growth, driven by the introduction of its PoNS treatment and various shareholder investments. The revenue of Helius Medical Technologies Inc has steadily increased since its founding, thanks to the support of its customers and investors. In summary, Helius Medical Technologies Inc is a leading company in the field of medical technology. Through innovative research and development, the company has achieved impressive success in a short period of time. The PoNS treatment is a groundbreaking technology that will gain global significance in the future. Helius Medical Technologies Inc remains focused on growth, with a strong vision that enables it to improve the quality of healthcare worldwide. Helius Medical Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Helius Medical Technologies's P/S Ratio

Helius Medical Technologies's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Helius Medical Technologies's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Helius Medical Technologies's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Helius Medical Technologies’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Helius Medical Technologies stock

What is the price-to-earnings ratio of Helius Medical Technologies?

The price-earnings ratio of Helius Medical Technologies is currently 1.78.

How has the price-earnings ratio of Helius Medical Technologies changed compared to last year?

The price-to-earnings ratio of Helius Medical Technologies has increased by -75.04% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Helius Medical Technologies high compared to other companies?

Yes, the price-to-earnings ratio of Helius Medical Technologies is high compared to other companies.

How does an increase in the price-earnings ratio of Helius Medical Technologies affect the company?

An increase in the price-earnings ratio of Helius Medical Technologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Helius Medical Technologies affect the company?

A decrease in the price-earnings ratio of Helius Medical Technologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Helius Medical Technologies?

Some factors that influence the price-earnings ratio of Helius Medical Technologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Helius Medical Technologies pay?

Over the past 12 months, Helius Medical Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Helius Medical Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Helius Medical Technologies?

The current dividend yield of Helius Medical Technologies is .

When does Helius Medical Technologies pay dividends?

Helius Medical Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Helius Medical Technologies?

Helius Medical Technologies paid dividends every year for the past 0 years.

What is the dividend of Helius Medical Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Helius Medical Technologies located?

Helius Medical Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Helius Medical Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Helius Medical Technologies from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Helius Medical Technologies pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Helius Medical Technologies in the year 2023?

In the year 2023, Helius Medical Technologies distributed 0 USD as dividends.

In which currency does Helius Medical Technologies pay out the dividend?

The dividends of Helius Medical Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Helius Medical Technologies

Our stock analysis for Helius Medical Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Helius Medical Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.